.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,842,714

« Back to Dashboard

Claims for Patent: 7,842,714

Title:Ketorolac tromethamine compositions for treating ocular pain
Abstract:The present invention provides an aqueous ophthalmic solution having an effective amount of ketorolac which includes carboxymethyl cellulose in an aqueous solution wherein the concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
Inventor(s): Farnes; Eldon Q. (Laguna Beach, CA), Attar; Mayssa (Placentia, CA), Schiffman; Rhett M. (Laguna Beach, CA), Chang; Chin-Ming (Tustin, CA), Graham; Richard S. (Irvine, CA), Welty; Devin F. (Foothill Ranch, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:12/396,131
Patent Claims: 1. A topical aqueous ophthalmic solution having the following components: a. 0.45% w/v ketorolac tromethamine; b. about 0.325% w/v carboxymethyl cellulose, medium viscosity; c. about 0.175% w/v carboxymethyl cellulose, high viscosity; d. about 0.7% w/v NaCl; e. about 0.2% w/v sodium citrate dihydrate; f. at least one buffer selected from the group consisting of sodium hydroxide (1N) and hydrochloric acid (1N) to adjust the pH to about 6.8; and g. water.

2. A topical aqueous ophthalmic solution having the following components: a. ketorolac tromethamine 0.45% w/v; b. carboxymethyl cellulose, medium viscosity 0.325% w/v; c. carboxymethyl cellulose, high viscosity 0.175% w/v; d. sodium citrate dihydrate 0.2% w/v; e. at least one buffer to adjust the pH to about 6.8; and f. water.

3. A topical aqueous ophthalmic solution having the following components: a. ketorolac tromethamine 0.45% w/v; b. carboxymethyl cellulose, medium viscosity 0.325% w/v; c. carboxymethyl cellulose, high viscosity 0.175% w/v; d. NaCl 0.7% w/v; e. sodium citrate dihydrate 0.2% w/v; f. sodium hydroxide (1N) and hydrochloric acid (1N) to adjust the pH to 6.8; and g. water.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc